{ "as_of": "2026-11-06", "cmr": "ca-cm-kg/CSE/DTC", "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.", "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# Defence Therapeutics Inc (CSE: DTC) — research page\n\nAs of 2026-11-06 · ca-cm-kg · record version 1\n\n## Identity and listing\n\nDefence Therapeutics Inc is listed on the CSE under the ticker DTC. Its ISIN is CA24463V1013; its LEI is not on the record. Its security type is Corporate, its sector is Life Sciences, and its jurisdiction is not on the record. Its segment is not on the record. The issuer is listed and not halted.\n\n## The disclosure read\n\nThe record holds 22 filings in the twelve months to 2026-11-06, all of them newswire releases, on 18 filing days. The median gap between filing days is 16 days. The latest filing is dated 2026-10-23, 14 days before the record date. The CSE median cadence is 19.5 days across 724 issuers, and the Life Sciences sector median is 17.5 days across 200 issuers. The CSE median latency is 17.0 days and the Life Sciences sector median latency is 14 days. The CSE median filings count is 6.0 and the sector median is 7.0.\n\n## Auditor\n\nThe auditor of record is Crowe MacKay LLP; its location is not on the record. The record holds no auditor changes.\n\n## Events and halts\n\nThe record holds no listing, delisting, name change, domicile change or segment move lines. The halt flag is clear: listed, not halted.\n\n## Orderability\n\nUnder the rule version acm-68000/ca/kyp-know-your-product-ni-31-103/r1, chapter as of 2026-11-04, the outcome for Paragraph (o) of the definition is signal ACM-200 and is determinable. The outcome for Paragraph (q) of the definition is signal ACM-200 and is determinable.\n\n## Coverage\n\nThe field has not been read, so no research houses are recorded on the issuer's investor-relations page.\n\n## Open research\n\nThe field has not been read, so no openly published research notes are recorded.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe market's vintage is not sealed. Years 2021 through 2026 are sealed in the store but not served as of a date, and the as-of door answers not_sealed. The live record began on 2026-09-10.\n\n## Sources\n\n7 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://thecse.com/api/webapi/listed-companies/ (identity.exchange)\n- https://www.investing.com/equities/defence-therapeutics (identity.isin)\n- https://mcp.ca-cm-kg.ai/events/CSE/DTC (the disclosure lines)\n- https://iiroc.mediaroom.com/index.php?s=2429&l=100 (the halt flag)\n- https://thecse.com/listings/defence-therapeutics-inc/ (the auditor)\n- https://mcp.ca-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://mcp.ca-cm-kg.ai/record/CSE/DTC (the record)\n", "market": "CA", "node": "ca-cm-kg", "numbers": { "as_of_depth": { "issuer_years_sealed": [], "live_record_began": "2026-09-10", "node_history_from": null, "node_years_sealed": [], "note": "6 years are sealed in the CA store; their Replay split is not built, so the as-of door answers not_sealed and the record is the live record as of 2026-11-06", "record_version": 1, "sealed": false, "store_years_sealed_not_served": [ "2021", "2022", "2023", "2024", "2025", "2026" ] }, "auditor": { "auditor": { "read_by": "CSE", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://thecse.com/listings/defence-therapeutics-inc/", "state": "sourced", "value": "Crowe MacKay LLP" }, "auditor_firm_id": { "market": "CA", "state": "not_on_record" }, "auditor_location": { "market": "CA", "state": "not_on_record" }, "changes": [] }, "cmr": "ca-cm-kg/CSE/DTC", "coverage": { "note": "the coverage field has not been read for this issuer", "state": "not_read" }, "disclosure": { "against": { "exchange": { "issuers": 724, "median_cadence_gap_days": 19.5, "median_filings": 6, "median_latency_days": 17, "name": "CSE" }, "sector": { "issuers": 200, "median_cadence_gap_days": 17.5, "median_filings": 7, "median_latency_days": 14, "name": "Life Sciences" } }, "by_type": { "newswire_release": 22 }, "cadence_median_gap_days": 16, "filing_days": 18, "filings": 22, "latency_days": 14, "latest": [ { "category": null, "date": "2026-10-23", "source": "https://www.newsfilecorp.com/release/320679/Defence-Therapeutics-Announces-Convertible-Debenture-Interest-Payment", "title": "Defence Therapeutics Announces Convertible Debenture Interest Payment", "type": "newswire_release" }, { "category": null, "date": "2026-10-19", "source": "https://www.newsfilecorp.com/release/319586/Defence-Therapeutics-Wins-Best-Poster-Award-and-Takes-Center-Stage-at-World-ADC-San-Diego-2026-a-Key-Recognition-in-the-Field-Highlighting-the-Potential-of-Its-Accum-Platform", "title": "Defence Therapeutics Wins Best Poster Award and Takes Center Stage at World ADC San Diego 2026, a Key Recognition in the Field Highlighting the Potential of Its Accum Platform", "type": "newswire_release" }, { "category": null, "date": "2026-09-08", "source": "https://www.newsfilecorp.com/release/313184/Defence-Therapeutics-CEO-Highlights-Recent-Progress-and-Outlines-Strategic-Priorities-in-Letter-to-Shareholders", "title": "Defence Therapeutics CEO Highlights Recent Progress and Outlines Strategic Priorities in Letter to Shareholders", "type": "newswire_release" }, { "category": null, "date": "2026-09-04", "source": "https://www.newsfilecorp.com/release/313180/Defence-Therapeutics-Provides-Updates-on-Sharing-Agreement", "title": "Defence Therapeutics Provides Updates on Sharing Agreement", "type": "newswire_release" }, { "category": null, "date": "2026-08-04", "source": "https://www.newsfilecorp.com/release/307697/Defence-Therapeutics-Appoints-Dr.-Amie-Phinney-as-President-and-Chief-Executive-Officer", "title": "Defence Therapeutics Appoints Dr. Amie Phinney as President and Chief Executive Officer", "type": "newswire_release" } ], "latest_filing_date": "2026-10-23", "read": "the node's event lines (list_events_since), as get_filings serves them", "source": "https://mcp.ca-cm-kg.ai/events/CSE/DTC", "window": { "from": "2025-11-06", "to": "2026-11-06" } }, "identity": { "exchange": { "read_by": "thecse.com listed-companies API (exchange list)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://thecse.com/api/webapi/listed-companies/", "state": "sourced", "value": "CSE" }, "isin": { "read_by": "Tavily search + regex extraction from page text", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://www.investing.com/equities/defence-therapeutics", "state": "sourced", "value": "CA24463V1013" }, "jurisdiction": { "market": "CA", "reason": "not searched", "state": "not_on_record" }, "lei": { "market": "CA", "reason": "ISIN not in the GLEIF ISIN-to-LEI mapping file", "state": "not_on_record" }, "name": { "read_by": "thecse.com listed-companies API (exchange list)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://thecse.com/api/webapi/listed-companies/", "state": "sourced", "value": "Defence Therapeutics Inc" }, "sector": { "read_by": "thecse.com listed-companies API (exchange list)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://thecse.com/api/webapi/listed-companies/", "state": "sourced", "value": "Life Sciences" }, "security_type": { "read_by": "thecse.com listed-companies API (exchange list)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://thecse.com/api/webapi/listed-companies/", "state": "sourced", "value": "Corporate" }, "segment": { "market": "CA", "state": "not_on_record" }, "ticker": { "read_by": "thecse.com listed-companies API (exchange list)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://thecse.com/api/webapi/listed-companies/", "state": "sourced", "value": "DTC" }, "website": { "market": "CA", "state": "not_on_record" } }, "licensed": { "columns": [ "licensor", "entitlement", "title", "date", "source" ], "rows": [], "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded." }, "lifecycle": { "delisting": [], "domicile_change": [], "listing": [], "name_change": [], "segment_move": [] }, "market": "CA", "node": "ca-cm-kg", "numbers_hash": "sha256:1f482e916c784a48b3737036f8f4762398e094a9028b6935c18bdaad8953cce8", "open_research": { "rows": [], "state": "not_read" }, "orderability": { "chapter_as_of": "2026-11-04", "client_categories": [ "Paragraph (o) of the definition", "Paragraph (q) of the definition" ], "outcomes": { "Paragraph (o) of the definition": { "determinable": true, "signal": "ACM-200" }, "Paragraph (q) of the definition": { "determinable": true, "signal": "ACM-200" } }, "read": { "basis": "one live read per instrument class, halt state and client category on this market; this issuer's group", "chapter": "https://mcp.ca-cm-kg.ai/book/aio.json", "door": "https://mcp.ca-cm-kg.ai/mcp", "tool": "get_orderability" }, "rule_version": "acm-68000/ca/kyp-know-your-product-ni-31-103/r1", "section": "ca.aio.v11" }, "record": { "as_of": "2026-11-06", "url": "https://mcp.ca-cm-kg.ai/record/CSE/DTC", "version": 1 }, "schema": "research-numbers v0.1 (USR-01, 2026-11-11)", "status": { "read_date": "2026-11-08", "source": "https://iiroc.mediaroom.com/index.php?s=2429&l=100", "value": "listed, not halted" } }, "numbers_hash": "sha256:1f482e916c784a48b3737036f8f4762398e094a9028b6935c18bdaad8953cce8", "path": "/ca/CSE/DTC", "schema": "research-page v0.1 (USR-02, 2026-11-11)", "sections": [ { "id": "identity", "text": "Defence Therapeutics Inc is listed on the CSE under the ticker DTC. Its ISIN is CA24463V1013; its LEI is not on the record. Its security type is Corporate, its sector is Life Sciences, and its jurisdiction is not on the record. Its segment is not on the record. The issuer is listed and not halted.", "title": "Identity and listing" }, { "id": "disclosure", "text": "The record holds 22 filings in the twelve months to 2026-11-06, all of them newswire releases, on 18 filing days. The median gap between filing days is 16 days. The latest filing is dated 2026-10-23, 14 days before the record date. The CSE median cadence is 19.5 days across 724 issuers, and the Life Sciences sector median is 17.5 days across 200 issuers. The CSE median latency is 17.0 days and the Life Sciences sector median latency is 14 days. The CSE median filings count is 6.0 and the sector median is 7.0.", "title": "The disclosure read" }, { "id": "auditor", "text": "The auditor of record is Crowe MacKay LLP; its location is not on the record. The record holds no auditor changes.", "title": "Auditor" }, { "id": "events", "text": "The record holds no listing, delisting, name change, domicile change or segment move lines. The halt flag is clear: listed, not halted.", "title": "Events and halts" }, { "id": "orderability", "text": "Under the rule version acm-68000/ca/kyp-know-your-product-ni-31-103/r1, chapter as of 2026-11-04, the outcome for Paragraph (o) of the definition is signal ACM-200 and is determinable. The outcome for Paragraph (q) of the definition is signal ACM-200 and is determinable.", "title": "Orderability" }, { "id": "coverage", "text": "The field has not been read, so no research houses are recorded on the issuer's investor-relations page.", "title": "Coverage" }, { "id": "open_research", "text": "The field has not been read, so no openly published research notes are recorded.", "title": "Open research" }, { "id": "licensed", "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.", "title": "Licensed" }, { "id": "depth", "text": "The market's vintage is not sealed. Years 2021 through 2026 are sealed in the store but not served as of a date, and the as-of door answers not_sealed. The live record began on 2026-09-10.", "title": "As-of depth" }, { "id": "sources", "text": "7 source pages are named on this page; every value above carries its own source page and read date in the numbers.", "title": "Sources" } ], "sources": [ { "for": "identity.exchange", "source": "https://thecse.com/api/webapi/listed-companies/" }, { "for": "identity.isin", "source": "https://www.investing.com/equities/defence-therapeutics" }, { "for": "the disclosure lines", "source": "https://mcp.ca-cm-kg.ai/events/CSE/DTC" }, { "for": "the halt flag", "source": "https://iiroc.mediaroom.com/index.php?s=2429&l=100" }, { "for": "the auditor", "source": "https://thecse.com/listings/defence-therapeutics-inc/" }, { "for": "the orderability chapter", "source": "https://mcp.ca-cm-kg.ai/book/aio.json" }, { "for": "the record", "source": "https://mcp.ca-cm-kg.ai/record/CSE/DTC" } ], "title": "Defence Therapeutics Inc (DTC) — research page", "writer": { "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers", "engine": "claude-haiku-5-5" } }